Gastrointestinal mucormycosis: An evolving disease

Gastroenterology and Hepatology

Volumn 8, Issue 2, 2012, Pages 140-142

  Spellberg, Brad ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ECHINOCANDIN; POLYENE;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL FEATURE; COLON; COMORBIDITY; CORTICOSTEROID THERAPY; CROHN DISEASE; DISEASE ASSOCIATION; FEVER; FUNGAL STRAIN; GASTROINTESTINAL DISEASE; HEMATOCHEZIA; HISTOPATHOLOGY; HUMAN; ILEUM; MUCORMYCOSIS; NAUSEA AND VOMITING; NECROTIZING ENTEROCOLITIS; NOTE; RISK FACTOR; STEM CELL TRANSPLANTATION; STOMACH; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84856913397     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (51)

1. Hibbett DS, Binder M, Bischoff JF, et al. A higher-level phylogenetic classification of the Fungi. Mycol Res. 2007;111:509-547.
2. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634-653.
3. Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J Jr, Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis. 2009;48:1743-1751.
4. Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005;18:556-569.
5. Gatling RR. Gastric mucormycosis in a newborn infant; a case report. AMA Arch Pathol. 1959;67:249-255.
6. Kahn LB. Gastric mucormycosis: report of a case with a review of the literature. S Afr Med J. 1963;37:1265-1269.
7. Sharma MC, Gill SS, Kashyap S, et al. Gastrointestinal mucormycosis-an uncommon isolated mucormycosis. Indian J Gastroenterol. 1998;17:131-133.
8. Reimund E, Ramos A. Disseminated neonatal gastrointestinal mucormycosis: a case report and review of the literature. Pediatr Pathol. 1994;14:385-389.
9. Kecskes S, Reynolds G, Bennett G. Survival after gastrointestinal mucormycosis in a neonate. J Paediatr Child Health. 1997;33:356-359.
10. Kline MW. Mucormycosis in children: review of the literature and report of cases. Pediatr Infect Dis. 1985;4:672-676.
11. Craig NM, Lueder FL, Pensler JM, et al. Disseminated Rhizopus infection in a premature infant. Pediatr Dermatol. 1994;11:346-350.
12. Amin SB, Ryan RM, Metlay LA, Watson WJ. Absidia corymbifera infections in neonates. Clin Infect Dis. 1998;26:990-992.
13. Vadeboncoeur C, Walton JM, Raisen J, Soucy P, Lau H, Rubin S. Gastrointestinal mucormycosis causing an acute abdomen in the immunocompromised pediatric patient-three cases. J Pediatr Surg. 1994;29:1248-1249.
14. White CB, Barcia PJ, Bass JW. Neonatal zygomycotic necrotizing cellulitis. Pediatrics. 1986;78:100-102.
15. Woodward A, McTigue C, Hogg G, Watkins A, Tan H. Mucormycosis of the neonatal gut: a "new" disease or a variant of necrotizing enterocolitis? J Pediatr Surg. 1992;27:737-740.
16. Diven SC, Angel CA, Hawkins HK, Rowen JL, Shattuck KE. Intestinal zygomycosis due to Absidia corymbifera mimicking necrotizing enterocolitis in a preterm neonate. J Perinatol. 2004;24:794-796.
17. Siu KL, Lee WH. A rare cause of intestinal perforation in an extreme low birth weight infant-gastrointestinal mucormycosis: a case report. J Perinatol. 2004;24:319-321.
18. Nissen MD, Jana AK, Cole MJ, Grierson JM, Gilbert GL. Neonatal gastrointestinal mucormycosis mimicking necrotizing enterocolitis. Acta Paediatr. 1999;88:1290-1293.
19. Suh IW, Park CS, Lee MS, et al. Hepatic and small bowel mucormycosis after chemotherapy in a patient with acute lymphocytic leukemia. J Korean Med Sci. 2000;15:351-354.
20. ter Borg F, Kuijper EJ, van der Lelie H. Fatal mucormycosis presenting as an appendiceal mass with metastatic spread to the liver during chemotherapy-induced granulocytopenia. Scand J Infect Dis. 1990;22:499-501.
21. Brullet E, Andreu X, Elias J, Roig J, Cervantes M. Gastric mucormycosis in a patient with acquired immunodeficiency syndrome [letter]. Gastrointest Endosc. 1993;39:106-107.
22. Hosseini M, Lee J. Gastrointestinal mucormycosis mimicking ischemic colitis in a patient with systemic lupus erythematosus. Am J Gastroenterol. 1998;93:1360-1362.
23. Singh N, Gayowski T, Singh J, Yu VL. Invasive gastrointestinal zygomycosis in a liver transplant recipient: case report and review of zygomycosis in solid-organ transplant recipients. Clin Infect Dis. 1995;20:617-620.
24. Martinez EJ, Cancio MR, Sinnott JT 4th, Vincent AL, Brantley SG. Nonfatal gastric mucormycosis in a renal transplant recipient. South Med J. 1997;90:341-344.
25. Mazza D, Gugenheim J, Baldini E, Mouiel J. Gastrointestinal mucormycosis and liver transplantation; a case report and review of the literature [letter]. Transpl Int. 1999;12:297-298.
26. Knoop C, Antoine M, Vachiéry JL, et al. Gastric perforation due to mucormycosis after heart-lung and heart transplantation. Transplantation. 1998;66:932-935.
27. Oliver MR, Van Voorhis WC, Boeckh M, Mattson D, Bowden RA. Hepatic mucormycosis in a bone marrow transplant recipient who ingested naturopathic medicine. Clin Infect Dis. 1996;22:521-524.
28. Maravi-Poma E, Rodriguez-Tudela JL, de Jalon JG, et al. Outbreak of gastric mucormycosis associated with the use of wooden tongue depressors in critically ill patients. Intensive Care Med. 2004;30:724-728.
29. Winkler S, Susani S, Willinger B, et al. Gastric mucormycosis due to Rhizopus oryzae in a renal transplant recipient. J Clin Microbiol. 1996;34:2585-2587.
30. Corley DA, Lindeman N, Ostroff JW. Survival with early diagnosis of invasive gastric mucormycosis in a heart transplant patient. Gastrointest Endosc. 1997;46:452-454.
31. Garg PK, Gupta N, Gautam V, Hadke NS. Gastric zygomycosis: unusual cause of gastric perforation in an immunocompetent patient. South Med J. 2008;101:449-450.
32. Goswami R, Cabrera-Kapetanos Y, Gupta MP, Thakkar S, Bhanot N. Necrotic gastric ulcer in an elderly patient: a rare case of gastric zygomycosis. South Med J. 2010;103:387-388.
33. Benjamin S. Primary gastric mucormycosis: role of preexisting ulcerative and erosive lesions. J Postgrad Med. 2009;55:73-74.
34. Chhaya V, Gupta S, Arnaout A. Mucormycosis causing giant gastric ulcers. Endoscopy. 2011;43 Suppl 2 UCTN:E289-E290.
35. Shiva Prasad BN, Shenoy A, Nataraj KS. Primary gastrointestinal mucormycosis in an immunocompetent person. J Postgrad Med. 2008;54:211-213.
36. Al-Rikabi AC, Al-Dohayan AD, Al-Boukai AA. Invasive mucormycosis in benign gastric ulcer. Saudi Med J. 2000;21:287-290.
37. Johnson CB, Ahmeti M, Tyroch AH, Zuckerman MJ, Hakim MN. Gastric mucormycosis as a cause of life-threatening upper gastrointestinal bleeding in a trauma patient. Am Surg. 2010;76:E76-E77.
38. Morton J, Nguyen V, Ali T. Mucormycosis of the intestine: a rare complication in Crohn's disease. Gastroenterol Hepatol (N Y). 2012;8:137-140.
39. Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008;47:503-509.
40. Nithyanandam S, Jacob MS, Battu RR, Thomas RK, Correa MA, D'Souza O. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Indian J Ophthalmol. 2003;51:231-236.
41. Peterson KL, Wang M, Canalis RF, Abemayor E. Rhinocerebral mucormycosis: evolution of the disease and treatment options. Laryngoscope. 1997;107:855-862.
42. Khor BS, Lee MH, Leu HS, Liu JW. Rhinocerebral mucormycosis in Taiwan. J Microbiol Immunol Infect. 2003;36:266-269.
43. Petrikkos G, Skiada A, Sambatakou H, et al. Mucormycosis: ten-year experience at a tertiary-care center in Greece. Eur J Clin Microbiol Infect Dis. 2003;22:753-756.
44. Tedder M, Spratt JA, Anstadt MP, Hegde SS, Tedder SD, Lowe JE. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg. 1994;57:1044-1050.
45. Pavie J, Lafaurie M, Lacroix C, et al. Successful treatment of pulmonary mucormycosis in an allogenic bone-marrow transplant recipient with combined medical and surgical therapy. Scand J Infect Dis. 2004;36:767-769.
46. Reid VJ, Solnik DL, Daskalakis T, Sheka KP. Management of bronchovascular mucormycosis in a diabetic: a surgical success. Ann Thorac Surg. 2004;78:1449-1451.
47. Asai K, Suzuki K, Takahashi T, Ito Y, Kazui T, Kita Y. Pulmonary resection with chest wall removal and reconstruction for invasive pulmonary mucormycosis during antileukemia chemotherapy. Jpn J Thorac Cardiovasc Surg. 2003;51:163-166.
48. Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis. 2000;30:851-856.
49. Kontoyiannis DP, Lionakis MS, Lewis RE, et al. Zygomycosis in a tertiarycare cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis. 2005;191:1350-1360.
50. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002;34:909-917.
51. Gleissner B, Schilling A, Anagnostopolous I, Siehl I, Thiel E. Improved outcome of zygomycosis in patients with hematological diseases? Leuk Lymphoma. 2004;45:1351-1360.